期刊文献+

社区获得性肺炎左氧氟沙星序贯疗法的临床评价与成本效果分析 被引量:1

Observation on therapeutic effect of sequential therapy with levofloxacin on community acquired pneumonia
下载PDF
导出
摘要 目的探讨左氧氟沙星序贯疗法治疗社区获得性肺炎的疗效。方法将社区获得性肺炎有效病例134例分为序贯治疗组(68例)和对照组(66例),序贯治疗组采用左氧氟沙星序贯疗法,对照组采用静脉滴注疗法。结果2组治愈率比较无显著性差异(P〉0.05),序贯治疗组治疗费用、不良反应均明显低于对照组(P〈0.01或0.05)。结论左氧氟沙星序贯疗法治疗社区获得性肺炎疗效确切,可缩短住院时间,降低医疗费用,减少不良反应发生,使患者依从性提高,是治疗社区获得性肺炎的理想疗法。 Objective To evaluate the efficacy of sequential treatment of levofloxacin on community acquired pneumonia. Methods 134 patients with community acquired pneumonia were divided into levofloxacin group( n = 68 ) and control group( n = 66) treated with Cefuroxime. The 68 inpatients with CAP in our hospital were treated with levofloxaein 400 mg a day of intravenous for 3 to 4 days, then changed to oral administration for 7 to 11 days. The 66 controls received levofloxaein intravenously for 11 days. Results There was no significant difference in efficacy rate between these two groups;there were less adverse reactions and lower costs in levofloxacin group. Conclusion Levofloxaein may be offered as an alternative to clinicians for treatment of community acquired pneumonia. Sequential therapy of levofloxa- cin for community acquired pneumonia was reliable and save the patients, money and shorten their hospital stays.
出处 《临床内科杂志》 CAS 2009年第9期608-610,共3页 Journal of Clinical Internal Medicine
关键词 社区获得性肺炎 左氧氟沙星 序贯疗法 Community acquired pneumonia Levofloxacin Sequential therapy
  • 相关文献

参考文献8

  • 1Anderson VR, Perry CM. Levofloxacin : a review of its use as a highdose, short-course treatment for bacterial infection. Drugs, 2008,68: 535 -565.
  • 2Denes E. Antibiotherapy for acute CAP in adults. Med Mal Infect, 2006,36:718-733.
  • 3社区获得性肺炎诊断和治疗指南(一)[J].全科医学临床与教育,2007,5(4):270-272. 被引量:38
  • 4Chidiac C. Acute community-acquired pneumonia. A review of clinical trials. Med Mal Infect ,2006,36:650-666.
  • 5Endimiani A, Brigante G, Bettaccini AA, et al. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia. BMC Infect Dis ,2005,5 : 106.
  • 6Samsa GP, Matchar DB, Hamett J, et al. A cost-minimization analysis comparing azithromyein-based and levofloxacin-based protocols for the treatment of patients hospitalized with eommunity-aequired pneumonia : results from the CAP-IN trial. Chest,2005,128:3246-3254.
  • 7Oucu S, Erdem H, Pahsa A. Therapeutic options for pneumococcal pneumonia in Turkey. Clin Ther,2005 ,27 :674-683.
  • 8Wasserfallen JB, Erard V, Cometta A, et al. Cost-effectiveness of fullcourse oral levofloxaein in severe community-acquired pneumonia. Eur Respir J ,2004,24:644-648.

共引文献37

同被引文献12

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部